CP 316311

CAS No. 175139-41-0

CP 316311( —— )

Catalog No. M33325 CAS No. 175139-41-0

CP 316311 is a specific CRF1 receptor antagonist with potential antidepressant activity and may be used in the study of depression.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 445 Get Quote
5MG 506 Get Quote
10MG 649 Get Quote
25MG 854 Get Quote
50MG 1159 Get Quote
100MG 1512 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CP 316311
  • Note
    Research use only, not for human use.
  • Brief Description
    CP 316311 is a specific CRF1 receptor antagonist with potential antidepressant activity and may be used in the study of depression.
  • Description
    CP 316311 is a potent and selective CRF1 receptor antagonist with an IC50 value of 6.8 nM.
  • In Vitro
    CP 316311 fully antagonizes CRF-stimulated adenylate cyclase activity in rat cortex and at human CRF1 receptors endogenously expressed in IMR32 cells with apparent Ki values of 7.6 and 8.5 nM, respectively.
  • In Vivo
    CP 316311 (3.2 mg/kg) inhibits 125I-oCRF binding by >80% in rats. CP 316311 significantly attenuates activation of the hypothalamic?pituitary?adrenal (HPA) axis, with an MED value of 10 mg/kg, p.o. CP 316311 blocks the effects of both the exogenous and endogenous CRF in the CNS. CP 316311 blocks the effects induced by the exogeneous or endogeneous CRF in the brain in rat models.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    CRF Receptor
  • Recptor
    CRFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    175139-41-0
  • Formula Weight
    327.46
  • Molecular Formula
    C21H29NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N=1C(OC=2C(=CC(=CC2C)C)C)=C(C(OC(CC)CC)=CC1C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chen YL, et al. Synthesis and SAR of 2-aryloxy-4-alkoxy-pyridines as potent orally active corticotropin-releasing factor 1 receptor antagonists. J Med Chem. 2008 Mar 13;51(5):1377-84.?
molnova catalog
related products
  • CRF (6-33)

    Corticotropin-releasing factor binding protein (CRFBP) inhibitor peptide; displaces CRF from CRFBP. Suppresses body weight gain and increases motor activity in obese rats in vivo.

  • K 41498

    Potent and highly selective CRF2 receptor antagonist (Ki values are 0.66, 0.62 and 425 nM for human CRF2α, CRF2β and CRF1 receptors respectively). Inhibits sauvagine-stimulated cAMP accumulation in hCRF2α- and hCRF2β-expressing cells. In rats in vivo, blocks urocortin-induced hypotension following systemic administration.

  • Urotensin I

    Urotensin I is, 41-aa neuropeptide, acts as an agonist of CRF receptor with pEC50s of 11.46, 9.36 and 9.85 for human CRF1, human CRF2 and rat CRF2α receptors in CHO cells, and Kis of 0.4, 1.8, and 5.7 nM for hCRF1, rCRF2α and mCRF2β receptors, respectively. Urotensin-I was first isolated from the urophysis of the white sucker, and has been shown to decrease blood pressure in the rat. UI consists of 41 aa residues with an amidated C-terminus.